Team:UIUC Illinois
From 2013.igem.org
(Difference between revisions)
Line 58: | Line 58: | ||
<body> | <body> | ||
- | < | + | <a href="https://2004.igem.org"> |
- | < | + | <img src="https://2004.igem.org/images/SBC04_People.jpg" alt="2004 iGEM from Above" title="2004 iGEM from Above" style="float:left; width:300px; height=200px; border:2px solid #000; margin:5px 30px 10px 30px"> |
+ | </a> | ||
+ | |||
<table border="1" cellspacing="0"> | <table border="1" cellspacing="0"> | ||
<tbody> | <tbody> | ||
Line 69: | Line 71: | ||
<tr><td><a href="https://2013.igem.org/UIUC_Illinois/Achievements"><linkBox>Achievements</linkBox></a></td></tr> | <tr><td><a href="https://2013.igem.org/UIUC_Illinois/Achievements"><linkBox>Achievements</linkBox></a></td></tr> | ||
<tr><td><a href="https://2013.igem.org/UIUC_Illinois/Sponsors"><linkBox> Sponsors </linkBox></a></td></tr> | <tr><td><a href="https://2013.igem.org/UIUC_Illinois/Sponsors"><linkBox> Sponsors </linkBox></a></td></tr> | ||
- | |||
- | |||
<tr><td><a href="https://2012.igem.org/Team:UIUC-Illinois"target="blank"><linkBox>2012 UIUC Team</linkBox></a></td> | <tr><td><a href="https://2012.igem.org/Team:UIUC-Illinois"target="blank"><linkBox>2012 UIUC Team</linkBox></a></td> | ||
<tr><td><a href="https://igem.org"target="blank"><linkBox>iGEM Website</linkBox></a></td></tr> | <tr><td><a href="https://igem.org"target="blank"><linkBox>iGEM Website</linkBox></a></td></tr> | ||
Line 77: | Line 77: | ||
</div> | </div> | ||
- | |||
- | |||
- | |||
- | |||
- | |||
<h1>Project Description</h1> | <h1>Project Description</h1> | ||
<h2>Cardiovascular disease (CVD) has been the leading cause of death in the United States for over twenty years and is becoming a severe global health issue. CVD is highly associated with the buildup of plaque in arteries, a disease known as Atherosclerosis. Trimethylamine N-oxide (TMAO) is a known proatherogenic substance, and is abundant in carnivorous humans and those who consume energy drinks. It is the goal of the University of Illinois at Urbana Champaign (UIUC) iGEM Team to lower the amount of TMAO found in such individuals and therefore reduce the risk of atherosclerosis for those afflicted.TMAO is produced when the gut microbiota process the amino acid derivatives L-carnitine and choline. These metabolites are abundant in red meats and energy drinks, and are important bodily compounds; however, humans are intrinsically capable of producing the necessary amounts. When these substances are consumed, specific gut bacteria convert L-carnitine and choline into a harmful byproduct trimethylamine (TMA.) To protect itself, the liver oxidizes TMA into TMAO. | <h2>Cardiovascular disease (CVD) has been the leading cause of death in the United States for over twenty years and is becoming a severe global health issue. CVD is highly associated with the buildup of plaque in arteries, a disease known as Atherosclerosis. Trimethylamine N-oxide (TMAO) is a known proatherogenic substance, and is abundant in carnivorous humans and those who consume energy drinks. It is the goal of the University of Illinois at Urbana Champaign (UIUC) iGEM Team to lower the amount of TMAO found in such individuals and therefore reduce the risk of atherosclerosis for those afflicted.TMAO is produced when the gut microbiota process the amino acid derivatives L-carnitine and choline. These metabolites are abundant in red meats and energy drinks, and are important bodily compounds; however, humans are intrinsically capable of producing the necessary amounts. When these substances are consumed, specific gut bacteria convert L-carnitine and choline into a harmful byproduct trimethylamine (TMA.) To protect itself, the liver oxidizes TMA into TMAO. |
Revision as of 13:42, 15 August 2013